Where will the Biden-Harris plan to cut insulin prices help the most diabetics? Check this map.
Talk is cheap. Insulin isn’t.
The Biden-Harris administration plans to cut the soaring price of 10 vital Medicare Part D medications including insulin through price negotiations with Big Pharma.
More than 37 million Americans live with diabetes and a quarter of them rely on insulin to stay alive.
43 Republican Senators and 193 House Republicans voted against Insulin price cap at $35/month.
“43 Republicans voted to keep insulin at $1,200/month instead of $35. Every Republican will ask you to be outraged that gas is $5 instead of $3. In the GOP world, $1,200 for life-saving insulin in fair play but $5 for gas is an outrage. Vote them all out.” – MarketRealist
Check this map to see how many diabetics live in your county. The Medicare beneficiaries among them will benefit from the Biden-Harris plan to cut insulin prices. Many more will still struggle with high insulin prices because Republicans voted against the $35 price cap. Republican talk is cheap. Insulin prices aren’t.
Stop the drug price gouging
Obscene Big Pharma profits provides the money to lobby Republicans to block any reforms to cut runaway drug prices. Big Pharma CEOs make millions. GOP politicians get drug lobby donations. Seniors pay the bill through unaffordable drug prices.
THE BIDEN ADMINISTRATION included short-acting insulin in its list of 10 drugs for which Medicare will negotiate lower prices, power vested in the White House by the Inflation Reduction Act.
The Inflation Reduction Act (IRA) was passed in the face of one of the heftiest barrages of lobbying in congressional history, with the pharmaceutical industry spending more than $700 million over 2021 and 2022 much of it aimed at stopping the legislation, watering it down, or undermining its implementation.
Big Pharma lobbying
The industry succeeded in narrowing the scope of the new law, with only 10 drugs eligible for negotiation in 2023. But the effort to stop the administration from using that authority to target blockbuster drugs failed spectacularly, as the White House list includes medications that seniors spend billions on in out-of-pocket costs alone, never mind the fees paid by Medicare itself. The US accounts for just shy of 15 percent of the global insulation market, their populace pays for nearly half of the pharmaceutical industry’s annual insulin revenue. – Independent
TakeAway: Stop Big Pharma greed that’s killing Americans. Hold your reps accountable for their votes. Shouldn’t they care more for their voters than their Big Pharma donors?
Deepak
DemLabs
DISCLAIMER: ALTHOUGH THE DATA FOUND IN THIS BLOG AND INFOGRAPHIC HAS BEEN PRODUCED AND PROCESSED FROM SOURCES BELIEVED TO BE RELIABLE, NO WARRANTY EXPRESSED OR IMPLIED CAN BE MADE REGARDING THE ACCURACY, COMPLETENESS, LEGALITY OR RELIABILITY OF ANY SUCH INFORMATION. THIS DISCLAIMER APPLIES TO ANY USES OF THE INFORMATION WHETHER ISOLATED OR AGGREGATE USES THEREOF
Recent Articles:
Follow the Big Pharma greed opposing plan to cut prices for 10 vital Medicare drugs
Justice for Sale: Luxury trips, tax cuts for billionaires and Supreme Court Ethics in United States vs. Moore
Political hate speech grooms killers
Follow the money behind Vivek Ramaswamy
Visualizing Justice: Free Visual Database to Track Georgia’s RICO Indictments and Surrenders
